Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial
Titel:
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial
Auteur:
Finkel, Richard S. Finanger, Erika Vandenborne, Krista Sweeney, H. Lee Tennekoon, Gihan Shieh, Perry B. Willcocks, Rebecca Walter, Glenn Rooney, William D. Forbes, Sean C. Triplett, William T. Yum, Sabrina W. Mancini, Maria MacDougall, James Fretzen, Angelika Bista, Pradeep Nichols, Andrew Donovan, Joanne M.